[1]
Y. Y. Marushko, G. B. Mankovsky, and A. A. Levadska, “Inclisiran Usage in Very High-Risk Patients with Dyslipidemia Resistant to Statins and Ezetimibe Therapy”, ujcvs, vol. 32, no. 2, pp. 33-37, Jun. 2024.